GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aelis Farma SA (XPAR:AELIS) » Definitions » Net Intangibles Purchase And Sale

Aelis Farma (XPAR:AELIS) Net Intangibles Purchase And Sale : €-0.09 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Aelis Farma Net Intangibles Purchase And Sale?

Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Aelis Farma's net Intangibles purchase and sale for the six months ended in Dec. 2023 was €-0.01 Mil. Its net Intangibles purchase and sale for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.09 Mil.

Aelis Farma Net Intangibles Purchase And Sale Historical Data

The historical data trend for Aelis Farma's Net Intangibles Purchase And Sale can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aelis Farma Net Intangibles Purchase And Sale Chart

Aelis Farma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Intangibles Purchase And Sale
Get a 7-Day Free Trial -0.04 -0.04 -0.03 -0.14 -0.09

Aelis Farma Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Intangibles Purchase And Sale Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.03 -0.12 -0.01 -0.08 -0.01

Aelis Farma Net Intangibles Purchase And Sale Calculation

Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Net Intangibles Purchase And Sale for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aelis Farma Net Intangibles Purchase And Sale Related Terms

Thank you for viewing the detailed overview of Aelis Farma's Net Intangibles Purchase And Sale provided by GuruFocus.com. Please click on the following links to see related term pages.

Aelis Farma (XPAR:AELIS) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aelis Farma SA (XPAR:AELIS) » Definitions » Net Intangibles Purchase And Sale
Comparable Companies
XPAR:IPH XPAR:IVA XPAR:MEDCL XPAR:GNFT XPAR:TNG XPAR:DBV XPAR:NANO XPAR:ADOC XPAR:ALSEN XPAR:OSE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
69O:Germany
Address
146, rue Leo Saignat, Bordeaux, FRA, 33077
Website
https://www.aelisfarma.com
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases.

Aelis Farma (XPAR:AELIS) Headlines

No Headlines